10q10k10q10k.net

vs

Side-by-side financial comparison of CHS INC (CHSCN) and Ingredion Inc (INGR), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.

CHS INC is the larger business by last-quarter revenue ($8.9B vs $1.8B, roughly 5.0× Ingredion Inc). Ingredion Inc runs the higher net margin — 2.9% vs 9.5%, a 6.6% gap on every dollar of revenue. On growth, Ingredion Inc posted the faster year-over-year revenue change (-2.4% vs -4.6%). Ingredion Inc produced more free cash flow last quarter ($270.0M vs $-453.8M). Over the past eight quarters, CHS INC's revenue compounded faster (-1.2% CAGR vs -3.4%).

CHS Inc. is a Fortune 500 secondary cooperative owned by United States agricultural cooperatives, farmers, ranchers, and thousands of preferred stock holders. Based in Inver Grove Heights, Minnesota, CHS owns and operates various food processing and wholesale, farm supply, financial services and retail businesses. It also distributes Cenex brand fuel in 19 midwestern and western states as one of North America's largest c-store networks. It is a co-owner of Ventura Foods, a vegetable oil proce...

Ingredion Inc. is an American food and beverage ingredient provider based in Westchester, Illinois, producing mainly starches, non-GMO sweeteners, stevia, and pea protein. The company turns corn, tapioca, potatoes, plant-based stevia, grains, fruits, gums and other vegetables into ingredients for the food, beverage, brewing, and pharmaceutical industries and numerous industrial sectors. It has about 12,000 employees in 44 locations, and customers in excess of 120 countries.

CHSCN vs INGR — Head-to-Head

Bigger by revenue
CHSCN
CHSCN
5.0× larger
CHSCN
$8.9B
$1.8B
INGR
Growing faster (revenue YoY)
INGR
INGR
+2.2% gap
INGR
-2.4%
-4.6%
CHSCN
Higher net margin
INGR
INGR
6.6% more per $
INGR
9.5%
2.9%
CHSCN
More free cash flow
INGR
INGR
$723.8M more FCF
INGR
$270.0M
$-453.8M
CHSCN
Faster 2-yr revenue CAGR
CHSCN
CHSCN
Annualised
CHSCN
-1.2%
-3.4%
INGR

Income Statement — Q1 2026 vs Q4 2025

Metric
CHSCN
CHSCN
INGR
INGR
Revenue
$8.9B
$1.8B
Net Profit
$260.5M
$167.0M
Gross Margin
4.4%
24.5%
Operating Margin
1.4%
12.5%
Net Margin
2.9%
9.5%
Revenue YoY
-4.6%
-2.4%
Net Profit YoY
6.4%
72.2%
EPS (diluted)
$2.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.

Revenue
CHSCN
CHSCN
INGR
INGR
Q4 25
$8.9B
$1.8B
Q3 25
$13.2B
$1.8B
Q2 25
$9.8B
$1.8B
Q1 25
$3.2B
$1.8B
Q4 24
$9.3B
$1.8B
Q3 24
$9.2B
$1.9B
Q2 24
$9.6B
$1.9B
Q1 24
$9.1B
$1.9B
Net Profit
CHSCN
CHSCN
INGR
INGR
Q4 25
$260.5M
$167.0M
Q3 25
$196.7M
$171.0M
Q2 25
$232.2M
$196.0M
Q1 25
$-75.8M
$197.0M
Q4 24
$244.8M
$97.0M
Q3 24
$111.8M
$188.0M
Q2 24
$297.3M
$148.0M
Q1 24
$170.3M
$216.0M
Gross Margin
CHSCN
CHSCN
INGR
INGR
Q4 25
4.4%
24.5%
Q3 25
2.5%
25.1%
Q2 25
3.4%
26.0%
Q1 25
2.4%
25.7%
Q4 24
4.3%
24.9%
Q3 24
3.0%
25.6%
Q2 24
4.9%
23.7%
Q1 24
4.0%
22.2%
Operating Margin
CHSCN
CHSCN
INGR
INGR
Q4 25
1.4%
12.5%
Q3 25
0.4%
13.7%
Q2 25
0.7%
14.8%
Q1 25
-5.4%
15.2%
Q4 24
1.5%
9.0%
Q3 24
-0.3%
14.3%
Q2 24
1.6%
12.8%
Q1 24
0.7%
11.3%
Net Margin
CHSCN
CHSCN
INGR
INGR
Q4 25
2.9%
9.5%
Q3 25
1.5%
9.4%
Q2 25
2.4%
10.7%
Q1 25
-2.4%
10.9%
Q4 24
2.6%
5.4%
Q3 24
1.2%
10.1%
Q2 24
3.1%
7.9%
Q1 24
1.9%
11.5%
EPS (diluted)
CHSCN
CHSCN
INGR
INGR
Q4 25
$2.58
Q3 25
$2.61
Q2 25
$2.99
Q1 25
$3.00
Q4 24
$1.43
Q3 24
$2.83
Q2 24
$2.22
Q1 24
$3.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.

Metric
CHSCN
CHSCN
INGR
INGR
Cash + ST InvestmentsLiquidity on hand
$374.7M
$1.0B
Total DebtLower is stronger
$1.7B
Stockholders' EquityBook value
$11.2B
$4.3B
Total Assets
$20.7B
$7.9B
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Cash + ST Investments
CHSCN
CHSCN
INGR
INGR
Q4 25
$374.7M
$1.0B
Q3 25
$327.8M
$915.0M
Q2 25
$323.9M
$861.0M
Q1 25
$433.3M
$837.0M
Q4 24
$795.6M
$997.0M
Q3 24
$1.3B
$877.0M
Q2 24
$310.1M
$505.0M
Q1 24
$633.3M
$438.0M
Total Debt
CHSCN
CHSCN
INGR
INGR
Q4 25
$1.7B
Q3 25
$1.7B
Q2 25
$1.8B
Q1 25
$1.8B
Q4 24
$1.8B
Q3 24
$1.8B
Q2 24
$1.7B
Q1 24
$1.7B
Stockholders' Equity
CHSCN
CHSCN
INGR
INGR
Q4 25
$11.2B
$4.3B
Q3 25
$11.1B
$4.2B
Q2 25
$10.8B
$4.2B
Q1 25
$10.7B
$4.0B
Q4 24
$10.8B
$3.8B
Q3 24
$10.8B
$4.0B
Q2 24
$10.9B
$3.7B
Q1 24
$10.8B
$3.7B
Total Assets
CHSCN
CHSCN
INGR
INGR
Q4 25
$20.7B
$7.9B
Q3 25
$18.9B
$7.8B
Q2 25
$19.7B
$7.8B
Q1 25
$20.1B
$7.5B
Q4 24
$19.6B
$7.4B
Q3 24
$18.7B
$7.5B
Q2 24
$18.5B
$7.2B
Q1 24
$19.2B
$7.3B
Debt / Equity
CHSCN
CHSCN
INGR
INGR
Q4 25
0.16×
Q3 25
0.16×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.17×
Q3 24
0.17×
Q2 24
0.15×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.

Metric
CHSCN
CHSCN
INGR
INGR
Operating Cash FlowLast quarter
$-337.8M
$405.0M
Free Cash FlowOCF − Capex
$-453.8M
$270.0M
FCF MarginFCF / Revenue
-5.1%
15.4%
Capex IntensityCapex / Revenue; lower = less reinvestment burden
1.3%
7.7%
Cash ConversionOCF / Net Profit; >1× = earnings back up with cash
-1.30×
2.43×
TTM Free Cash FlowTrailing 4 quarters
$-60.0M
$511.0M

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Operating Cash Flow
CHSCN
CHSCN
INGR
INGR
Q4 25
$-337.8M
$405.0M
Q3 25
$1.3B
$277.0M
Q2 25
$696.6M
$185.0M
Q1 25
$-1.0B
$77.0M
Q4 24
$-294.0M
$436.0M
Q3 24
$1.1B
$479.0M
Q2 24
$556.9M
$312.0M
Q1 24
$-249.6M
$209.0M
Free Cash Flow
CHSCN
CHSCN
INGR
INGR
Q4 25
$-453.8M
$270.0M
Q3 25
$1.1B
$172.0M
Q2 25
$520.6M
$84.0M
Q1 25
$-1.2B
$-15.0M
Q4 24
$-486.6M
$311.0M
Q3 24
$845.8M
$429.0M
Q2 24
$361.6M
$257.0M
Q1 24
$-453.3M
$144.0M
FCF Margin
CHSCN
CHSCN
INGR
INGR
Q4 25
-5.1%
15.4%
Q3 25
8.1%
9.5%
Q2 25
5.3%
4.6%
Q1 25
-38.1%
-0.8%
Q4 24
-5.2%
17.3%
Q3 24
9.2%
22.9%
Q2 24
3.8%
13.7%
Q1 24
-5.0%
7.7%
Capex Intensity
CHSCN
CHSCN
INGR
INGR
Q4 25
1.3%
7.7%
Q3 25
1.5%
5.8%
Q2 25
1.8%
5.5%
Q1 25
5.2%
5.1%
Q4 24
2.1%
6.9%
Q3 24
2.9%
2.7%
Q2 24
2.0%
2.9%
Q1 24
2.2%
3.5%
Cash Conversion
CHSCN
CHSCN
INGR
INGR
Q4 25
-1.30×
2.43×
Q3 25
6.46×
1.62×
Q2 25
3.00×
0.94×
Q1 25
0.39×
Q4 24
-1.20×
4.49×
Q3 24
9.96×
2.55×
Q2 24
1.87×
2.11×
Q1 24
-1.47×
0.97×

Financial Flow Comparison

Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.

Revenue Breakdown by Segment

CHSCN
CHSCN

Grains$5.2B59%
Agronomy$1.2B14%
CF Nitrogen LLC$1.1B12%
Ventura Foods Llc$838.2M9%
Other$283.9M3%
ASC Topic815$198.7M2%
West Central Ag Services$18.0M0%
Other Guidance$1.4M0%

INGR
INGR

Food And Industrial Ingredients LATAM Segment$599.0M34%
Texture And Healthful Solutions Segment$598.0M34%
Food And Industrial Ingredients U.S.Canada Segment$486.0M28%
Other$74.0M4%

Related Comparisons